|
|
||||||||
Institute of Experimental and Clinical Pharmacology and Toxicology, Medical University of Lübeck, D-23538 Lübeck, Germany
Kinins are vasoactive peptide hormones
that can confer protection against the development of hypertension.
Because their efficacy is greatly influenced by the rate of enzymatic
degradation, the activities of various kininases in plasma and blood of
spontaneously hypertensive rats (SHR) were compared with those in
normotensive Wistar-Kyoto rats (WKY) to identify pathogenic
alterations. Either plasma or whole blood was incubated with bradykinin
(10 µM). Bradykinin and kinin metabolites were measured by
high-performance liquid chromatography. Kininase activities were
determined by cumulative inhibition of angiotensin I-converting enzyme
(ACE), carboxypeptidase N (CPN), and aminopeptidase P (APP), using
selective inhibitors. Plasma of WKY rats degraded bradykinin at a rate
of 13.3 ± 0.94 µmol · min
1 · l
1. The
enzymes ACE, APP, and CPN represented 92% of this kininase activity,
with relative contributions of 52, 25, and 16%, respectively. Inclusion of blood cells at physiological concentrations did not extend
the activities of these plasma kininases further. No differences of
kinin degradation were found between WKY and SHR. The identical conditions of kinin degradation in WKY and SHR suggest no pathogenic role of kininases in the SHR model of genetic hypertension.
kinins; metabolism; angiotensin I-converting enzyme; aminopeptidase P; carboxypeptidase N
This article has been cited by other articles:
![]() |
E. B. Oliveira, L. L. Souza, D. O. Sivieri Jr, L. B. Bispo-da-Silva, H. J. V. Pereira, C. M. Costa-Neto, M. V. Sousa, and M. C. O. Salgado Carboxypeptidase B and other kininases of the rat coronary and mesenteric arterial bed perfusates Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3550 - H3557. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Sulpizio, M. A. Pullen, R. M. Edwards, and D. P. Brooks The Effect of Acute Angiotensin-Converting Enzyme and Neutral Endopeptidase 24.11 Inhibition on Plasma Extravasation in the Rat J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 1141 - 1147. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Matsui, K. Nagy-Bojarsky, P. Laakkonen, S. Krieger, K. Mechtler, S. Uchida, S. Geleff, D.-H. Kang, R. J. Johnson, and D. Kerjaschki Lymphatic Microvessels in the Rat Remnant Kidney Model of Renal Fibrosis: Aminopeptidase P and Podoplanin Are Discriminatory Markers for Endothelial Cells of Blood and Lymphatic Vessels J. Am. Soc. Nephrol., August 1, 2003; 14(8): 1981 - 1989. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Koch, M. Wendorf, A. Dendorfer, S. Wolfrum, K. Schulze, F. Spillmann, H.-P. Schultheiss, and C. Tschope Cardiac kinin level in experimental diabetes mellitus: role of kininases Am J Physiol Heart Circ Physiol, June 5, 2003; 285(1): H418 - H423. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. D. Xiao, S. Fuchs, J. M. Cole, K. M. Disher, R. L. Sutliff, and K. E. Bernstein Regulation of Cardiovascular Signaling by Kinins and Products of Similar Converting-Enzyme Systems: Role of bradykinin in angiotensin-converting enzyme knockout mice Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H1969 - H1977. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |